Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Premaitha Health PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

17 Sep 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Premaitha Health PLC (NIPT-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Sep 2016 Thomson Reuters Stock Report 11 $25.00

Premaitha Health Plc (NIPT) - Financial Analysis Review

Premaitha Health Plc (NIPT) - Financial Analysis Review Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc...

13 Sep 2016 GlobalData 47 $300.00

Wright Investors Service Comprehensive Report for Premaitha Health PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

31 Aug 2016 Wright Reports 63 $75.00

Thomson Reuters Stock Report - Premaitha Health PLC (NIPT-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00

Premaitha Health (NIPT.L): Solid first year IONA sales; positive litigation update

Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA® uses complex...

20 Apr 2016 Hardman & Company 11 $115.00

Premaitha Health PLC: Downgraded to Average

02 Feb 2016 Sadif Analytics Prime 3 $10.00

Premaitha Health (NIPT.L): IONA®–Up, running and available on the NHS

Premaitha uses the latest advances in DNA sequencing technology for non-invasive prenatal screening tests. IONA estimates the...

28 Jan 2016 Hardman & Company 40 $426.00

Company Snapshot - Premaith Health

A director at Premaith Health bought 180,736 shares at 18p and the significance rating of the trade was 74/100. Is that info...

18 Dec 2015 Directors Deals Ltd. 1 $12.00

Premaitha Health (NIPT.L): Early IONA traction & investment agreement

Premaitha is a molecular diagnostics company that has used the latest advances in DNA technology to develop a non-invasive pr...

15 Dec 2015 Hardman & Company 8 $81.00